UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting

PloS one, 2021-08, Vol.16 (8), p.e0255798-e0255798

2021

Volltextzugriff (PDF)

NK cells propagate T cell immunity following in situ tumor vaccination

Cell reports (Cambridge), 2023-12, Vol.42 (12), p.113556-113556, Article 113556

2023

Volltextzugriff (PDF)

MAGE-C2 Promotes Growth and Tumorigenicity of Melanoma Cells, Phosphorylation of KAP1, and DNA Damage Repair

Journal of investigative dermatology, 2013-03, Vol.133 (3), p.759-767

2013

Volltextzugriff (PDF)

A Phase I Study of Immunization Using Particle-Mediated Epidermal Delivery of Genes for gp100 and GM-CSF into Uninvolved Skin of Melanoma Patients

Clinical cancer research, 2007-01, Vol.13 (2), p.540-549

2007

Volltextzugriff (PDF)

Development of a next-generation sequencing protocol for the canine T cell receptor beta chain repertoire

Veterinary immunology and immunopathology, 2024-02, Vol.268, p.110702-110702, Article 110702

2024

Volltextzugriff (PDF)

Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells

Mutation research. Reviews in mutation research, 2022-01, Vol.789, p.108414-108414, Article 108414

2022

Volltextzugriff (PDF)

Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma

Melanoma research, 2024-08, Vol.34 (4), p.307-318

2024

Volltextzugriff (PDF)

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma

Cancer Immunology, Immunotherapy, 2018-10, Vol.67 (10), p.1647-1658

2018

Volltextzugriff (PDF)

Enrichment of melanoma-associated T cells in 6-thioguanine-resistant T cells from metastatic melanoma patients

Melanoma research, 2020-02, Vol.30 (1), p.52-61

2020

Volltextzugriff (PDF)

Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma

Cancer Immunology, Immunotherapy, 2016-08, Vol.65 (8), p.897-907

2016

Volltextzugriff (PDF)

Abstract 2366: Pilot study of DNA microseeding to activate immune rejection of canine melanoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2366-2366

2016

Volltextzugriff (PDF)

OMIP‐008: Measurement of Th1 and Th2 cytokine polyfunctionality of human T cells

Cytometry. Part A, 2012-06, Vol.81A (6), p.450-452

2012

Volltextzugriff (PDF)

A conditional predictive p-value to compare a multinomial with an overdispersed multinomial in the analysis of T-cell populations

Biostatistics (Oxford, England), 2014-01, Vol.15 (1), p.129-139

2014

Volltextzugriff (PDF)

Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma

Veterinary medicine and science, 2017-08, Vol.3 (3), p.134-145

2017

Volltextzugriff (PDF)

In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells

Journal of immunological methods, 2011-02, Vol.365 (1-2), p.76-86

2011

Volltextzugriff (PDF)

Clonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patients

Environmental and molecular mutagenesis, 2008-12, Vol.49 (9), p.676-687

2008

Volltextzugriff (PDF)

Peptide induces CD4 +CD25 + and IL-10 + T cells and protection in airway allergy models

Vaccine, 2005-05, Vol.23 (24), p.3181-3186

2005

Volltextzugriff (PDF)

Enrichment of melanoma-associated T cells in 6-thioguanine-resistant T cells from the peripheral blood of a melanoma patient following successful treatment with immune checkpoint blockade

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21607-e21607

2018

Volltextzugriff (PDF)

Hepatitis-B surface antigen (HBsAg) powder formulation: process and stability assessment

Current drug delivery, 2007-01, Vol.4 (1), p.57-67

2007

Volltextzugriff (PDF)

An antigen-independent but not antigen-specific TH1 response provides protection in the murine airway inflammation model

Journal of allergy and clinical immunology, 2004-12, Vol.114 (6), p.1301-1308

2004

Volltextzugriff (PDF)

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative

PloS one, 2021-08, Vol.16 (8), p.e0255798

2021

Volltextzugriff (PDF)

Phase I/II trial of intratumoral administration of hu14.18-IL2, with local radiation, nivolumab, and ipilimumab in subjects with advanced melanoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS9591-TPS9591

2021

Volltextzugriff (PDF)

Immune responses to hepatitis B surface antigen following epidermal powder immunization

Immunology and cell biology, 2003-02, Vol.81 (1), p.52-58

2003

Volltextzugriff (PDF)

Abstract 2538: Immune responses to common melanoma-associated antigens following intratumoral injection of alpha-gal glycolipids in patients with advanced melanoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2538-2538

2014

Volltextzugriff (PDF)

Identification of in vivo 6-thioguanine-resistant T cells reactive to melanoma-associated antigens (40.15)

The Journal of immunology (1950), 2009-04, Vol.182 (1_Supplement), p.40-40.15

2009

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting

NK cells propagate T cell immunity following in situ tumor vaccination

MAGE-C2 Promotes Growth and Tumorigenicity of Melanoma Cells, Phosphorylation of KAP1, and DNA Damage Repair

A Phase I Study of Immunization Using Particle-Mediated Epidermal Delivery of Genes for gp100 and GM-CSF into Uninvolved Skin of Melanoma Patients

Development of a next-generation sequencing protocol for the canine T cell receptor beta chain repertoire

Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells

Administration of intratumoral GD2-directed interleukin-2 immunocytokine and local radiation therapy to activate immune rejection of spontaneous canine melanoma

Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma

Enrichment of melanoma-associated T cells in 6-thioguanine-resistant T cells from metastatic melanoma patients

Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma

Abstract 2366: Pilot study of DNA microseeding to activate immune rejection of canine melanoma

OMIP‐008: Measurement of Th1 and Th2 cytokine polyfunctionality of human T cells

A conditional predictive p-value to compare a multinomial with an overdispersed multinomial in the analysis of T-cell populations

Pilot study of safety and feasibility of DNA microseeding for treatment of spontaneous canine melanoma

In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells

Clonal expansions of 6-thioguanine resistant T lymphocytes in the blood and tumor of melanoma patients

Peptide induces CD4 +CD25 + and IL-10 + T cells and protection in airway allergy models

Enrichment of melanoma-associated T cells in 6-thioguanine-resistant T cells from the peripheral blood of a melanoma patient following successful treatment with immune checkpoint blockade

Hepatitis-B surface antigen (HBsAg) powder formulation: process and stability assessment

An antigen-independent but not antigen-specific TH1 response provides protection in the murine airway inflammation model

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative

Phase I/II trial of intratumoral administration of hu14.18-IL2, with local radiation, nivolumab, and ipilimumab in subjects with advanced melanoma

Immune responses to hepatitis B surface antigen following epidermal powder immunization

Abstract 2538: Immune responses to common melanoma-associated antigens following intratumoral injection of alpha-gal glycolipids in patients with advanced melanoma

Identification of in vivo 6-thioguanine-resistant T cells reactive to melanoma-associated antigens (40.15)

Suchergebnisse filtern